Please assess the completion status of the following clinical trial:

Trial Title: Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Meets criteria for alcohol dependence and post-traumatic stress disorder.~* Heavy drinking in the past 30 days (an average of more than 12 alcohol drinks per week with at least 1 day of 4 or more drinks).~* Successfully complete medical detoxification.~* Exhibit clinically significant trauma-related symptoms.~* Live in a commutable distance to the University of Pennsylvania and agree to follow-up visits.~* Aged between 18 and 65 years old.~* Able to provide an informed consent.~* Speak and read English.~Exclusion Criteria:~* Current diagnosis of any substance dependence other than alcohol, nicotine, or cannabis.~* Evidence of opiate use in the past 30 days.~* Significant risk of violence or history of serious violent behavior during the past year.~* Continued contact with an intimate partner if assault by the partner is the index trauma.~* Changes in dosage or medication for any SSRI treatment in the three months prior to entering the study.~* Unstable or serious medical illness.~* Current severe psychiatric symptom.~* Mental retardation or another pervasive developmental disorder.~* Use of an investigational medication in the past 30 days.~* Pregnant, nursing or not using reliable contraception.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Naltrexone alone (Type: ACTIVE_COMPARATOR): Naltrexone alone
- Naltrexone with CBT for PTSD (Type: ACTIVE_COMPARATOR): Naltrexone with CBT for PTSD
- Placebo with CBT for PTSD (Type: ACTIVE_COMPARATOR): Placebo with CBT for PTSD
- Placebo alone (Type: PLACEBO_COMPARATOR): Placebo alone

Based on this trial design, predict the completion outcome and termination type (if applicable).